Highly Potent & Oncology Technology Platform Brochure
Product Description
Corden Pharma International GmbH
-
DE
-
2015On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
Categories
Corden Pharma International GmbH
-
DE
-
2015On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
More Products from Corden Pharma International GmbH (32)
-
Product CordenPharma API Support Services
At any development stage and scale of synthesis CordenPharma’s services for contracted customers include all supporting activities that are required to be adequately cGMP compliant such as:
• Process Validation • Cleaning Validation • Batch Release • Analytical Method Development & Validation •... -
Product CordenPharma Drug Product Support Services
SUPPORT SERVICES FOR OUR CONTRACTED CUSTOMERS • Analytical Development • Validation Support • Regulatory Support • Clinical Supply Services -
Product CordenPharma Highly Potent APIs
With over 25 years of experience in the handling of Highly Potent Intermediates and Active Pharmaceutical Ingredients (APIs), CordenPharma utilises sophisticated technologies and the combined capabilities of multiple global cGMP facilities to produce Highly Potent pharmaceutical Drug Products and their API... -
Product WeylChem InnoTec > Innovative Fine chemical, Pharmaceutical and Electronic Industry Partner
WeylChem InnoTec are your innovative partner to the fine chemical, pharmaceutical and electronic industry. We provide world-class analytical, modern developmental and tailor-made manufacturing services. With our competencies in Analytics, Contract Development & Custom Synthesis, WeylChem InnoTec is you... -
Product CordenPharma BotaniChol® Plant-Based Cholesterol
Chemists at CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol based on botanical sources. This offers a large-scale production of highly needed cholesterol, which is used as part of the lipid cocktail ... -
Product CordenPharma ONE PARTNER CDMO Video
Your ONE PARTNER CDMO for Fully-Integrated Supply
As your ONE PARTNER CDMO, CordenPharma provides contract manufacturing of APIs, Excipients, Drug Products & Packaging in an integrated solution spanning all product life cycle stages, from preclinical to commercial, supported by dedicated regulator... -
Product Injectables Technology Platform Brochure
Your Expert Partner for Clinical & Commercial Sterile Injectable Drug Product Supply • Wide & balanced range of sterile injectable services, including capability for combining injectable drugs & devices (combination products) • Aseptic & Terminal Sterilization Fill & Finish Tech... -
Product Peptides, Lipids & Carbohydrates Technology Platform Brochure
Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates • A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids) • Lipids for support of mRNA vaccine production including Phospho... -
Product Small Molecules Technology Platform Brochure
Small Molecule Full-Service Partner of Choice from Advanced Intermediates to Drug Products • Integrated network of cGMP facilities across Europe and US • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction • Clinical (Phase I-III) and ongoing comme... -
Product CordenPharma Oligonucleotides Platform
Your Expert Partner for Oligonucleotide APIs - Process Development & Small-scale: scale-up to 10 mmol per run (small-scale equipment can also support early-stage supply) - Scale-up & Small to Medium-scale: scale-up to 100 mmol per run (supported by OligoPilotTM equipment) - Large-Scale Oligonucleotide Pr... -
Product CordenPharma's Early-Phase Peptide Centre of Excellence
In addition to the largest worldwide capacity of commercial SPPS peptide production up to batch sizes exceeding 400 kg (> 35 Amino Acids), and a yearly capacity of > 2 Metric Tons of Peptide, CordenPharma's multi-pronged approach to becoming the #1 peptide CDMO supplier extends to small-scale capabilities,... -
Product Early-Phase Oral Solid Dose Drug Product Innovation Centre of Excellence
CordenPharma’s Drug Product Innovation Centre of Excellence offers early phase formulation development and manufacturing services for Oral Solid Dose (OSD) drug products, including Bioavailability Enhancement technologies. In collaboration with our Solid State Centre of Excellence, we provide integrated AP...
Corden Pharma International GmbH resources (2)
-
News CordenPharma signs billion dollar agreement to manufacture new peptide
CordenPharma, the CDMO specialising in APIs, lipid excipients, and drug products, signs a new billion dollar contract to expand its manufacturing capabilities. -
Video Webinar On Demand > Critical Aspects of a Robust Highly Potent Compound Program > The Importance of Understanding Intangible Elements of Containment
Register for this Live (4-4-18) or on Demand webinar to learn how the most important (and often over-looked) aspect to a robust containment program is the strength of the intangible, softer elements. Discuss how to maximize the success of your engineering control investments and allow for continued alignment to your company’s commitment to providing a workplace free of recognized health & safety hazards.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance